CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension

Author： Bremer Troy   Man Albert   Kask Kalev   Diamond Cornelius  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.3, 2006-04, pp. : 271-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?

By Burnier Michel   Pruijm Menno   Wuerzner Gregoire  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 981-987

Informa Healthcare

Access to resources Recommend Favorite

Calcium Channel Antagonists in the Treatment of Hypertension

By Weber M.A.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 415-431

Adis International

Access to resources Recommend Favorite

Use of Calcium Channel Antagonists for the Treatment of Hypertension in the Elderly

By Hans-Michael Steffen  

Drugs & Aging, Vol. 21, Iss. 9, 2004-01 ,pp. : 565-581

Adis International

Access to resources Recommend Favorite

A Review of Calcium Channel Antagonists in the Treatment of Pediatric Hypertension

By Sahney Shobha  

Pediatric Drugs, Vol. 8, Iss. 6, 2006-01 ,pp. : 357-373

Adis International

Access to resources Recommend Favorite

N-type Calcium Channel Blockers: Novel Therapeutics for the Treatment of Pain

By  

Medicinal Chemistry, Vol. 2, Iss. 5, 2006-09 ,pp. : 535-543

Bentham Science Publishers

Access to resources Recommend Favorite